VEA
PBYI icon

Virtus ETF Advisers’s Puma Biotechnology PBYI Stock Holding History

Virtus ETF Advisers’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29,347
Closed -$188K – 556
2026
Q1 		$188K Sell
29,347
-17,825
-38% -$115K 0.09% 250
2025
Q4 		$281K Hold
47,172
– – 0.13% 180
2025
Q3 		$250K Sell
47,172
-8,259
-15% -$35K 0.14% 188
2025
Q2 		$190K Hold
55,431
– – 0.12% 212
2025
Q1 		$164K Buy
+55,431
New +$174K 0.11% 237
2019
Q4 		– Sell
-54,053
Closed -$582K – 494
2019
Q3 		$582K Sell
54,053
-9,089
-14% -$98.1K 0.12% 174
2019
Q2 		$803K Buy
63,142
+29,764
+89% +$685K 0.17% 184
2019
Q1 		$1.29M Buy
33,378
+7,119
+27% +$217K 2.76% 2
2018
Q4 		$534K Buy
26,259
+12,032
+85% +$361K 0.09% 74
2018
Q3 		$652K Buy
14,227
+975
+7% +$47K 0.07% 82
2018
Q2 		$784K Buy
13,252
+4,123
+45% +$239K 0.69% 40
2018
Q1 		$621K Sell
9,129
-532
-6% -$39.8K 0.54% 103
2017
Q4 		$955K Buy
9,661
+5,514
+133% +$617K 1.2% 31
2017
Q3 		$497K Buy
4,147
+380
+10% +$35.3K 0.07% 90
2017
Q2 		$329K Sell
3,767
-4,380
-54% -$245K 0.05% 99
2017
Q1 		$303K Buy
8,147
+781
+11% +$28.5K 0.05% 133
2016
Q4 		$226K Sell
7,366
-300
-4% -$13K 0.07% 165
2016
Q3 		$514K Hold
7,666
– – 0.25% 69
2016
Q2 		$228K Buy
7,666
+4,345
+131% +$136K 0.17% 117
2016
Q1 		$98K Buy
+3,321
New +$150K 0.14% 146

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtus ETF Advisers's PBYI Position: Q2 2026 in Review

Virtus ETF Advisers sold out of Puma Biotechnology (PBYI) in Q2 2026, closing a stake of 29,347 shares — an estimated $188K sold.

Virtus ETF Advisers first reported a position in PBYI in Q1 2016 and held it in 20 quarters. The position peaked at $1.29M in Q1 2019. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Virtus ETF Advisers reported no remaining Puma Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Virtus ETF Advisers sold 29,347 Puma Biotechnology shares in Q2 2026, an estimated $188K.
  • Virtus ETF Advisers first reported a position in Puma Biotechnology in Q1 2016 and held it in 20 quarters.
  • Virtus ETF Advisers's Puma Biotechnology position peaked at $1.29M in Q1 2019.
  • 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.